| Patents for A61K 49 - Preparations for testing in vivo (35,376) |
|---|
| 05/04/2005 | EP1028758B1 Radioactive compositions for the treatment of prostate tumors |
| 05/04/2005 | EP0994730B1 LABELLED FACTOR XIIIa SUBSTRATES |
| 05/03/2005 | US6889072 Method and apparatus for administration of contrast agents for use in magnetic resonance arteriography |
| 05/03/2005 | US6887854 Absorption, fluorescence; using light for optical medical diagnosis |
| 05/03/2005 | US6887469 Anti-idiotypic antibodies of vascular endothelial growth factor and use thereof as drugs |
| 04/28/2005 | WO2005037928A2 Compounds for dual photodiagnosis and therapy |
| 04/28/2005 | WO2005037711A1 Amphiphilic [5:1]- and [3:3]- hexakisadducts of fullerenes |
| 04/28/2005 | WO2005037325A1 X-ray contrast medium containing liposome and method for preparation thereof |
| 04/28/2005 | WO2005037324A1 Methods and compositions for modulating circadian rhythm |
| 04/28/2005 | WO2005037312A2 Binding molecules for the extra-domain b of fibronectin, used for the detection of atherosclerotic plaques |
| 04/28/2005 | WO2005037292A1 Mucous membrane bulging humor composition comprising chitosan derivative containing saccharide chain for use in condoscopic surgery |
| 04/28/2005 | WO2005002293A3 Cox-2-targeted imaging agents |
| 04/28/2005 | WO2004110250A3 Diagnostic method for atherosclerosis |
| 04/28/2005 | WO2004032839A3 Methods and formulations comprising agonists and antagonists of nuclear hormone receptors |
| 04/28/2005 | US20050090689 Such as gadolinium complexes of 10-[2-[(3,5-Bis[[(2,3-dihydroxypropyl)amino]-carbonyl]phenyl]amino]-2-oxoethyl]-1,4,7,10-tetraazacyclododecane-1,4,7-triacetic acid; for use as contrast agents, X-ray imaging, radionuclide imaging, ultrasound imaging and magnetic resonance imaging; biocompatability |
| 04/28/2005 | US20050090671 for human telomeres/telomerases; drug screening |
| 04/28/2005 | US20050090653 Metal complex compounds |
| 04/28/2005 | US20050090556 Method for treatment of external secretion disorders |
| 04/28/2005 | US20050090429 Photo-active backbone cyclized somatostatin analogs for photodynamic therapy and imaging |
| 04/28/2005 | US20050089868 Modulators of tissue regeneration |
| 04/28/2005 | US20050089510 Immunization against plaque forming diseases such as cardiovascular disorders with vaccines for disaggregation |
| 04/28/2005 | US20050089473 By administering one or more activators of an ATP-sensitive potassium channel in combination with one or more activators of a calcium-activated potassium channel to increase permeability of the drugs through the capillaries in the abnormal brain tissue |
| 04/28/2005 | US20050089472 Animal model for monitoring conditions of the mouth, nails, or teeth |
| 04/28/2005 | US20050089471 A reaction product of an antibody, protein, biomolecule, polysaccharide, or peptidomimetic, a luminescent dye, radionuclide, near infrared dye, a magnetically active isotope, a superparamagnetic particle, or a metal ion, and a linker moiety; diagnosis and monitoring of inflammatory diseases |
| 04/28/2005 | US20050089470 Labeled peptides for lectin-like oxidized low-density lipoprotein receptor (LOX-1) |
| 04/28/2005 | US20050087719 Magnetic nanodispersion with cyclodextrines and method for the production thereof |
| 04/28/2005 | CA2543148A1 Mucous membrane bulging humor composition comprising chitosan derivative containing saccharide chain for use in condoscopic surgery |
| 04/28/2005 | CA2542694A1 Compounds for dual photodiagnosis and therapy |
| 04/28/2005 | CA2540195A1 Amphiphilic [5:1]- and [3:3]- hexakisadducts of fullerenes |
| 04/27/2005 | EP1525856A2 Apparatus for applying a biopsy site marker |
| 04/27/2005 | EP1525478A2 SHIGA TOXIN B-SUBUNIT AS A VECTOR FOR TUMOR DIAGNOSIS AND DRUG DELIVERY TO GB sb 3 /sb EXPRESSING TUMORS |
| 04/27/2005 | EP1525223A2 Ox40 (=cd134) receptor agonists and therapeutic use |
| 04/27/2005 | EP1525003A1 Methods and contrast agents useful in quantifying nitric oxide |
| 04/27/2005 | EP1381311A4 Methods and reagents to acquire mri signals and images |
| 04/27/2005 | EP1217993B1 Bioadhesive nanoparticulate compositions having cationic surface stabilizers |
| 04/26/2005 | US6884579 Antidiabetic agents; side effect reduction |
| 04/26/2005 | US6884417 Sepsis |
| 04/26/2005 | US6884407 Methods for diagnostic imaging involving the use of a contrast agent and a coronary vasodilator |
| 04/21/2005 | WO2005035003A2 Compositions and methods for increasing drug efficiency |
| 04/21/2005 | WO2005034912A2 Ferromagnetic particles and methods |
| 04/21/2005 | WO2005012509A3 Method for immunotherapy of tumors |
| 04/21/2005 | WO2004108902A3 Biocompatible fluorescent silicon nanoparticles |
| 04/21/2005 | WO2004023099A3 Nanoengineered biophotonic hybrid device |
| 04/21/2005 | US20050085724 Biopsy cavity marking device and method |
| 04/21/2005 | US20050085711 Method and system for leading macromolecule substances into living target cells |
| 04/21/2005 | US20050084857 Breast tumor antigen for use as tool in diagnosis prevention and treatment of mammary gland cell proliferative disorders; antitumor agents |
| 04/21/2005 | US20050084538 Ultrasonic concentration of drug delivery capsules |
| 04/21/2005 | US20050084453 Mixing a sterol or a polyether modified phospholipid capable of forming a liposome with a supercritical carbon dioxide, contacting water-soluble nonionic iodine compound with phospholipid to form a liposome containing vesicles including the iodine compound; chlorine-free solvent |
| 04/21/2005 | US20050084451 Novel chelating agents and chelates and their use |
| 04/20/2005 | EP1523559A1 Cell wall mutants for delivery of biologically active compounds |
| 04/20/2005 | EP1523338A1 Steroid conjugates, their preparation and the use thereof |
| 04/20/2005 | EP1523337A2 Imaging method and device for carrying out said method |
| 04/20/2005 | EP1307446B1 Perfluoroalkyl-containing complexes comprising sugar residues, method for producing the same and use thereof |
| 04/20/2005 | CN1607963A Magnetic nanodispersion comprising cyclodextrines and method for the production thereof |
| 04/19/2005 | US6881586 Detection of preferential particles in sample; obtain sample, incubate with absorbent, detect retained particles |
| 04/19/2005 | US6881397 Long-lasting aqueous dispersions or suspensions of pressure-resistant gas-filled microvesicles and methods for the preparation thereof |
| 04/19/2005 | US6881183 Radioactive seed with multiple markers and method for using same |
| 04/14/2005 | WO2005032598A1 Polybiotin compounds for magnetic resonance imagining and drug delivery |
| 04/14/2005 | WO2005032512A2 Capsules of multilayered neutral polymer films associated by hydrogen bonding |
| 04/14/2005 | WO2005032369A1 Contrast media for use in medical and diagnostic procedures and methods of using the same |
| 04/14/2005 | WO2005032270A1 Method for assessing food palatability and preference in animals using a cognitive palatability assessment protocol (cpap) |
| 04/14/2005 | WO2005017522A3 Method for in vivo determination on tested animals of the efficient concentration of deuterium depleted water for cancer therapy |
| 04/14/2005 | WO2005011738A3 Polymeric conjugates containing phosphine - based chelating groups |
| 04/14/2005 | WO2004110373A3 Therapeutic vaccine compositions for the treatment of type 1 diabetes |
| 04/14/2005 | WO2004096990A3 Pathophysiology associated with a single gene (mass1) mutation underlying the robust audiogenic seizure phenotype in frings mice |
| 04/14/2005 | WO2004075032A3 In vivo fluorescence sensors, systems, and related methods operating in conjunction with fluorescent analytes |
| 04/14/2005 | WO2004036182A3 Methods for monitoring treatment of disease |
| 04/14/2005 | WO2003027228A3 Receptors and membrane-associated proteins |
| 04/14/2005 | US20050080339 Biopsy cavity marking device |
| 04/14/2005 | US20050080338 Breast inplants; collagen porous matrix for supporting breast tissue |
| 04/14/2005 | US20050080337 Biopsy site marker |
| 04/14/2005 | US20050079538 polynucleotides which identify and encode human secreted proteins (SECP); expression vectors, host cells, antibodies, agonists, and antagonists; drug screening; anticarcinogenic agents |
| 04/14/2005 | US20050079134 Calibration skin transfer efficiency ; using computer |
| 04/14/2005 | US20050079131 Oil nanoparticle overcoated with lipid, surfactant mixture; oil in water emulsions; contrast for magnetic resonance imaging |
| 04/14/2005 | CA2747947A1 Contrast media for use in medical and diagnostic procedures and methods of using the same |
| 04/14/2005 | CA2541974A1 Capsules of multilayered neutral polymer films associated by hydrogen bonding |
| 04/14/2005 | CA2540131A1 Polybiotin compounds for magnetic resonance imagining and drug delivery |
| 04/13/2005 | EP1522318A2 Heat stable coated colloidal iron oxides |
| 04/13/2005 | EP1522317A1 Implantable particles for tissue bulking and the treatment of gastroesophageal reflux disease, urinary incontinence, and skin wrinkles |
| 04/13/2005 | EP1521959A1 Method and apparatus for 3-d imaging of internal light sources |
| 04/13/2005 | EP1521822A2 Protein modification and maintenance molecules |
| 04/13/2005 | EP1521741A1 Imaging compounds |
| 04/13/2005 | EP1404293A4 Infection control system |
| 04/13/2005 | EP1301183A4 Functionalized active-nucleus complex sensor |
| 04/13/2005 | EP1214101A4 Method for detecting and killing epithelial cancer cells |
| 04/13/2005 | CN1606454A Antibody targeting compounds |
| 04/13/2005 | CN1196702C Bicyclic polyaminoacid metal complexes, method for preparing same and use in medical imaging |
| 04/13/2005 | CN1196497C Near infrared fluorescent contrast agent and fluorescence imaging |
| 04/12/2005 | US6878817 Low density lipoprotein binding proteins and their use in diagnosing and treating atherosclerosis |
| 04/12/2005 | US6878384 A polymeric hydrogel material that permits cellular ingrowth and has controlled rate of expansion optimized for delivery through microcatheter or catheter without need for a nonaqueous solvent or coating |
| 04/12/2005 | US6878369 Methods for treating urinary incontinence in mammals |
| 04/07/2005 | WO2005030268A1 Inherently radiopaque polymeric products for embolotherapy |
| 04/07/2005 | WO2005030267A1 Pharmaceutically enhanced low-energy radiosurgery |
| 04/07/2005 | WO2005030266A2 Optical imaging of colorectal cancer |
| 04/07/2005 | WO2005030265A2 Optical imaging of endometriosis |
| 04/07/2005 | WO2005030264A1 A method of evaluating organ function |
| 04/07/2005 | WO2005030263A1 Use of gas for the manufacture of a monitoring agent for diagnostic passage through the intestinal tract or exocrine function of the pancreas |
| 04/07/2005 | WO2005030262A1 Use of a gas for the manufacture of a diagnosing agent for diagnosing coronary perfusion |
| 04/07/2005 | WO2005030258A2 Small molecule compositions and methods for increasing drug efficiency using compositions thereof |
| 04/07/2005 | WO2005030254A2 Conjugates for photodynamic therapy |